Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC247

Durvalúmab og lyfjafræðilega viðunandi sölt þar af

  • Status:
    Veitt
  • Application date:
    14.1.2019
  • Application published:
    15.2.2019
  • Grant published:
    15.12.2021
  • Max expiry date:
    24.3.2034
  • Medicine name:
    Imfinzi
  • Medicine for children:
    Yes

Timeline

Today
14.1.2019Application
15.2.2019Publication
15.12.2021Registration
24.3.2034Expires

Marketing license

  • IS authorization number:
    EU/1/18/1322/001-002
  • Date:
    23.10.2018
  • Foreign authorization number:
    EU/1/18/1322
  • Date:
    21.9.2018

Owner

  • Name:
    Medimmune Limited
  • Address:
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 09.06.2025

Upload documents